Transient exposure of human myoblasts to tumor necrosis factor-α inhibits serum and insulin-like growth factor-I stimulated protein synthesis

Endocrinology

Volumn 138, Issue 10, 1997, Pages 4153-4159

  Frost, Robert A ^a,b   Lang, Charles H ^a,b   Gelato, Marie C ^a  

^a STONY BROOK UNIVERSITY   (United States)

^b PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; CYTOKINE; SOMATOMEDIN C; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; HORMONAL REGULATION; HORMONE ACTION; HUMAN; HUMAN CELL; MYOBLAST; MYOTUBE; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN SYNTHESIS; SERUM;

EID: 0030924558     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.138.10.5450     Document Type: Article

References (42)

1. Wojnar MM, Hawkins WG, Lang CH 1995 Nutritional support of the septic patient. Crit Care Clin 11:717-733
2. Toomey D, Redmond HP, Bouchier-Hayes D 1995 Mechanisms mediating cancer cachexia. Cancer 76:2418-2426
3. Pacy PJ, Preedy VR, Read M, Halliday D 1991 The effect of chronic alcohol ingestion on whole body and muscle protein synthesis: a stable isotope study. Alcohol 26:505-513
4. Coodley GO, Loveless MO, Mill JM 1994 The HIV wasting syndrome: a review. J AIDS 7:56-51
5. Kotler DP, Tierney AR, Wang T, Pierson RN 1989 Magnitude of body cell mass depletion and the timing of death from wasting in AIDS. Am J Clin Nutr 50:444-447
6. Gelato MC, Frost RA, DeCristofaro K, Garlick PJ, Lang CH, Steigbigel R, Fuhrer J, McNurlan MA 1996 Growth hormone deficiency and diminished anabolic response in muscle of HIV infected adults. Program of the 10th International Congress of Endocrinology, San Francisco, CA, 1996 Abstract P3-44
7. Mitch WE, Goldberg AL 1996 Mechanisms of muscle wasting: the role of the ubiquitin proteosome pathway. N Eng J Med 335:1897-1905
8. Cooney RN, Kimball SR, Vary TC 1997 Regulation of skeletal muscle protein turnover during sepsis: mechanisms and mediators. Shock 7:1-16
9. Ziegler TR, Gatzen C, Wilmore DW 1994 Strategies for attenuating protein catabolic responses in the critically ill. Ann Rev Med 45:459-480
10. Espat NJ, Moldawer LL, Copeland EM 1995 Cytokine-mediated alterations in host metabolism prevent nutritional repletion in cachectic cancer patients. J Surg Oncol 58:77-82
11. Jarasinski CV, Vary TC 1995 Insulin-like growth factor-I accelerates protein synthesis in skeletal muscle during sepsis. Am J Physiol 269:E977-E981
12. Fryburg DA 1994 Insulin-like growth factor-I exerts growth hormone and insulin-like actions on muscle protein metabolism. Am J Physiol 267:E331-336
13. Fan J, Molina PE, Gelato MC, Lang CH 1994 Differential tissue regulation of insulin like growth factor-I content and binding proteins after endotoxin. Endocrinology 134:1685-1692
14. Wojnar MM, Fan J, Frost RA, Gelato MC, Lang CH 1995 Alterations in the insulin-like growth factor system in trauma patients. Am J Physiol 37:R970-R977
15. Frost RA, Fuhrer J, Mariuz P, Lang CH, Gelato MC 1996 Wasting in the acquired immune deficiency syndrome is associated with multiple defects in the serum insulin-like growth factor system. Clin Endocrinol (Oxf) 44:501-514
16. Lang CH, Fan J, Frost RA, Gelato MC, Sakurai Y, Herndon DN, Wolfe RR 1996 Regulation of the insulin-like growth factor system by insulin in burn patients. J Clin Endocrinol Metab 81:2474-2480
17. Lang CH, Fan J, Cooney R, Vary T 1996 IL-1 receptor antagonist attenuates sepsis-induced alterations in the IGF system and protein synthesis. Am J Physiol 270:E430-E437
18. Tominaga M, Yamatani K, Igarashi M, Egushi H, Daimon M, Sekikawa A, Sasaki H 1995 Insulin-like growth factor resistance in peripheral tissue but not in liver in streptozotocin-induced diabetic rats. Endocr J 42:397-403
19. Roth E, Valentini L, Semsroth M, Holzenbein T, Winkler S, Blum WF, Ranke MB, Schemper M, Hammerle A, Korner J 1995 Resistance of nitrogen metabolism to growth hormone treatment in the early phase after injury of patients with multiple injuries. J Trauma 38:136-141
20. Givalois L, Dornand J, Mekaouche M, Solier MD, Bristow AF, Ixart G, Siaud P, Assenmacher I, Barbanel G 1994 Temporal cascade of plasma level surges in ACTH, corticosterone, and cytokines in endotoxin-challenged rats. Am J Physiol 266:R164-R170
21. Ertel W, Morrison MH, Wang P, Zheng F, Ayala A, Chaudry IH 1991 The complex pattern of cytokines and sepsis: association between prostoglandins, cachectin and interleukins. Ann Surg 214:141-148
22. Belec L, Meillet D, Hernvann A, Gresenguet G, Gheradi R 1994 Differential elevations of circulating interleukin 1 beta, tumor necrosis factor alpha, and interleukin-6 in AIDS-associated cachectic states. Clin Diagn Lab Immunol 1:117-120
23. Fan J, Char D, Bagby GJ, Gelato MC, Lang CH 1995 Regulation of insulin-like growth factor-I (IGF-I) and IGF-binding proteins by tumor necrosis factor. Am J Physiol 269:R1204-R1212
24. Moldawer LL Svaninger G, Gelin J, Lundholm K 1987 Interleukin 1 and tumor necrosis factor do not regulate protein balance in skeletal muscle. Am J Physiol 253:C755-C773
25. Llovera M, Lopez-Soriano FJ, Argiles JM 1993 Effect of tumor necrosis factor alpha on muscle protein-turnover in female Wistar rats. J Natl Can Inst 85:1334-1339
26. Garcia-Maritnez C, Lopez-Soriano FJ, Argiles JM 1993 Acute treatment with tumor necrosis factor alpha induces changes in protein metabolism in rat skeletal muscle. Mol Cell Biochem 125:11-1810
27. Llovera M, Lopez-Soriano FJ, Argiles JM 1993 Chronic tumor necrosis factor alpha treatment modifies protein turnover in rat tissues. Biochem Mol Biol Int 30:29-36
28. Blau HM, Webster C 1981 Isolation and characterization of human muscle cells. Proc Nat Acad Sci USA 78:5623-5627
29. Frost RA, Mazella J, Tseng L 1993 Insulin-like growth factor binding protein-1 inhibits the mitogenic effect of insulin like growth factors and progestins in human endometrial stromal cells. Biol Reprod 49:104-111
30. Bereket A, Wilson TA, Blethen SL, Fan J, Frost RA, Gelato MC, Lang CH 1996 Effect of short-term fasting on free/dissociable insulin-like growth factor 1 concentrations in normal human serum. J Clin Endocrinol Metab 81:4379-4384
31. Frost RA, Tseng L 1991 Insulin-like growth factor binding protein-1 is phosphorylated by cultured human endometrial stromal cells and multiple protein kinases in vitro. J Biol Chem 266:18082-18088
32. Ewton DZ, Florini JR 1990 Effects of insulin-like growth factors and transforming growth factor-β on the growth and differentiation of muscle cells in culture. Proc Soc Exp Biol Med 194:76-80
33. Ballard FJ, Read LC, Francis GL, Bagley CJ, Wallace JC 1986 Binding properties and biological potencies of insulin-like growth factors in L6 myoblasts. Biochem J 233:223-230
34. Begum N, Ragolia L 1996 Effect of tumor necrosis factor alpha on insulin action in cultured rat skeletal muscle cells. Endocrinology 137:2441-244636
35. Blat C, Villaudy J, Binoux M 1994 In vivo proteolysis of serum insulin-like growth factor (IGF) binding protein-3 results in increased availability of IGF to target cells. J Clin Invest 93:2286-2290
36. DeVrodede MA, Romanus JA, Standaert ML, Pollet RJ, Nissley SP, Rechler MM 1984 Interaction of insulin-like growth factors with a nonfusing mouse muscle cell line: binding, action, and receptor down-regulation. Endocrinology 114:1917-1929
37. Ferrari S, Thomas G 1994 S6 phosphorylation and the p70(S6)/p85(S6k). Crit Rev Biochem Mol Biol 29:385-413
38. Mendez R, Meyers MG, White MF, Rhoads RE 1996 Stimulation of protein synthesis, eukaryotic translation initiation factor 4E phosphorylation, and PHAS-I phosphorylation by insulin requires insulin receptor substrate 1 and phosphatidylinositol 3-kinase. Mol Cell Biol 16:2857-2864
39. Terada N, Patel HR, Takase K, Kohno K, Nairn AC, Gelfand EW 1994 Rapamycin selectively inhibits translation of mRNAs encoding elongation factors and ribosomal proteins. Proc Natl Acad Sci USA 91:11477-11481
40. Terada N, Franklin RA, Lucas JJ, Blenis J, Gelfand EW 1993 Failure of rapamycin to block proliferation once resting cells have entered the cell cycle despite inactivation of p 70 s6 kinase. J Biol Chem 268:12062-12068
41. Rosenblum MG, Donato NJ, Gutterman JU 1988 Characterization of human recombinant tumor necrosis factor-alpha antiproliferative effects on human cells in culture. Lymphokine Res 7:107-117
42. Palombella VJ, Vilcek J 1989 Mitogenic and cytotoxic actions of tumor necrosis factor in BALB/c3T3 cells. Role of phospholipase activation. J Biol Chem 264:18128-18136